Literature DB >> 6502653

Partial trisomy 16 as a result of familial 16;20 translocation.

E V Davison, J R Beesley.   

Abstract

Although trisomy 16 is well recognised in spontaneous abortuses, it is infrequent in livebirths and there is little information about the clinical effects. We report two sibs with partial trisomy 16q resulting in infant death. Both children were severely growth retarded with small elfin faces, prominent foreheads, low set ears, abnormal external genitalia, and intractable diarrhoea.

Entities:  

Mesh:

Year:  1984        PMID: 6502653      PMCID: PMC1049325          DOI: 10.1136/jmg.21.5.384

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  Metaphyseal dysostosis. Review of literature; study of a case with cytogenetic analysis.

Authors:  B J SCHMIDT; W BECAK; M L BECAK; I SOIBELMAN; A S da QUEIROZ; A P LORGA; F SECAF; C F ANTONIO; A A de CARVALHO
Journal:  J Pediatr       Date:  1963-07       Impact factor: 4.406

2.  A cytogenetic study of human spontaneous abortions using banding techniques.

Authors:  M R Creasy; J A Crolla; E D Alberman
Journal:  Hum Genet       Date:  1976-02-29       Impact factor: 4.132

3.  Partial trisomy 16q-.

Authors:  E Yunis; J T González; O M Torres de Caballero
Journal:  Hum Genet       Date:  1977-10-14       Impact factor: 4.132

4.  Group E triple cell line mosaicism with Sprengel's deformity and other asymmetrical congenital abnormalities. Report of a case.

Authors:  J A Backus; G G Darien
Journal:  Am J Clin Pathol       Date:  1968-04       Impact factor: 2.493

5.  Trisomy-16 in a mosaic carrier father and his aborted foetus.

Authors:  D T Arakaki; S H Waxman
Journal:  J Med Genet       Date:  1969-03       Impact factor: 6.318

6.  Trisomy 16p in a liveborn infant and a review of partial and full trisomy 16.

Authors:  S H Roberts; D P Duckett
Journal:  J Med Genet       Date:  1978-10       Impact factor: 6.318

7.  Trisomy 16q arising from a maternal 15p;16q translocation.

Authors:  M A Ridler; J A McKeown
Journal:  J Med Genet       Date:  1979-08       Impact factor: 6.318

  7 in total
  6 in total

Review 1.  Trisomy 16q23----qter arising from a maternal t(13;16)(p12;q23): case report and evidence of the reciprocal balanced maternal rearrangement by the Ag-NOR technique.

Authors:  J B Savary; F Vasseur; S Manouvrier; A Daudignon; O Lemaire; M Thieuleux; M Poher; P Lequien; M M Deminatti
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

2.  Duplication of 16q22-->qter confirmed by fluorescence in situ hybridisation and molecular analysis.

Authors:  R S Houlston; R M Renshaw; R S James; R Ironton; I K Temple
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

3.  Subtelomeric FISH analysis in 76 patients with syndromic developmental delay/intellectual disability.

Authors:  Elga F Belligni; Elisa Biamino; Cristina Molinatto; Jole Messa; Mauro Pierluigi; Francesca Faravelli; Orsetta Zuffardi; Giovanni B Ferrero; Margherita Cirillo Silengo
Journal:  Ital J Pediatr       Date:  2009-04-27       Impact factor: 2.638

Review 4.  Partial trisomy 16q21➔qter due to an unbalanced segregation of a maternally inherited balanced translocation 46,XX,t(15;16)(p13;q21): a case report and review of literature.

Authors:  R Mishra; C S Paththinige; N D Sirisena; S Nanayakkara; U G I U Kariyawasam; V H W Dissanayake
Journal:  BMC Pediatr       Date:  2018-01-08       Impact factor: 2.125

5.  Partial trisomy 16q and partial monosomy 7p of a fetus derivated from paternal balanced translocation: A case report.

Authors:  Hui-Hui Xie; Tong Liu; Jing-Bo Zhang; Jing-Fang Zhai; Ying Liu
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

6.  A rare description of pure partial trisomy of 16q12.2q24.3 and review of the literature.

Authors:  Joshua Manor; Daniela Dinu; Mahshid S Azamian; Weimin Bi; Sandra Darilek; Seema R Lalani
Journal:  Am J Med Genet A       Date:  2021-06-01       Impact factor: 2.578

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.